Abbonarsi

Comparison of breast density assessment between human eye and automated software on digital and synthetic mammography: Impact on breast cancer risk - 26/11/20

Doi : 10.1016/j.diii.2020.07.004 
M. Le Boulc’h a, A. Bekhouche a, b, E. Kermarrec a, A. Milon a, b, C. Abdel Wahab a, b, S. Zilberman a, c, N. Chabbert-Buffet a, c, I. Thomassin-Naggara a, b,
a APHP Sorbonne Université - Hôpital Tenon, Department of Radiology, 75020 Paris, France 
b Sorbonne Université, Institut des Sciences du Calcul et des Données Jussieu, Paris, France 
c APHP Sorbonne Université - Hôpital Tenon–Department of Gynecology & Obstetrics- Centre des femmes à risque de cancer du sein et de l’ovaire, 75020 Paris, France 

Corresponding author.

Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
Articolo gratuito.

Si connetta per beneficiarne

Highlights

Almost perfect agreement is obtained between senior and junior radiologists for breast density assessment on digital and synthetic mammography.
Substantial agreement in breast density assessment is obtained between radiologists and automated software.
Variability in breast density assessment between independent readers and automated software does not substantially alter estimation of breast cancer risk.

Il testo completo di questo articolo è disponibile in PDF.

Abstract

Purpose

To evaluate the agreement between automatic assessment software of breast density based on artificial intelligence (AI) and visual assessment by a senior and a junior radiologist, as well as the impact on the assessment of breast cancer risk (BCR) at 5 years.

Materials and methods

We retrospectively included 311 consecutive women (mean age, 55.6±8.5 [SD]; range: 40–74 years) without a personal history of breast cancer who underwent routine mammography between January 1, 2019 and February 28, 2019. Mammographic breast density (MBD) was independently evaluated by a junior and a senior reader on digital mammography (DM) and synthetic mammography (SM) using BI-RADS (5th edition) and by an AI software. For each MBD, BCR at 5 years was estimated per woman by the AI software. Interobserver agreement for MBD between the two readers and the AI software were evaluated by quadratic κ coefficients. Reproducibility of BCR was assessed by intraclass correlation coefficient (ICC).

Results

Agreement for MBD assessment on DM and SM was almost perfect between senior and junior radiologists (κ=0.88 [95% CI: 0.84–0.92] and κ=0.86 [95% CI: 0.82–0.90], respectively) and substantial between the senior radiologist and AI (κ=0.79; 95% CI: 0.73–0.84). There was substantial agreement between DM and SM for the senior radiologist (κ=0.79; 95% CI: 0.74–0.84). BCR evaluation at 5 years was highly reproducible between the two radiologists on DM and SM (ICC=0.98 [95% CI: 0.97–0.98] for both), between BCR evaluation based on DM and SM evaluated by the senior (ICC=0.96; 95% CI: 0.95–0.97) or junior radiologist (ICC=0.97; 95% CI: 0.96–0.98) and between the senior radiologist and AI (ICC=0.96; 95% CI: 0.95–0.97).

Conclusion

This preliminary study demonstrates a very good agreement for BCR evaluation based on the evaluation of MBD by a senior radiologist, junior radiologist and AI software.

Il testo completo di questo articolo è disponibile in PDF.

Keywords : MammoRisk®, Mammography, Breast density, Breast neoplasms, Artificial intelligence

Abbreviations : AI, BC, MBD, CNN, DM, ICC, SM, SD


Mappa


© 2020  Société française de radiologie. Pubblicato da Elsevier Masson SAS. Tutti i diritti riservati.
Aggiungere alla mia biblioteca Togliere dalla mia biblioteca Stampare
Esportazione

    Citazioni Export

  • File

  • Contenuto

Vol 101 - N° 12

P. 811-819 - Dicembre 2020 Ritorno al numero
Articolo precedente Articolo precedente
  • Artificial intelligence solution to classify pulmonary nodules on CT
  • D. Blanc, V. Racine, A. Khalil, M. Deloche, J.-A. Broyelle, I. Hammouamri, E. Sinitambirivoutin, M. Fiammante, E. Verdier, T. Besson, A. Sadate, M. Lederlin, F. Laurent, G. Chassagnon, G. Ferretti, Y. Diascorn, P.-Y. Brillet, Lucie Cassagnes, C. Caramella, A. Loubet, N. Abassebay, P. Cuingnet, M. Ohana, J. Behr, A. Ginzac, H. Veyssiere, X. Durando, I. Bousaïd, N. Lassau, J. Brehant
| Articolo seguente Articolo seguente
  • Morphological imaging and CT histogram analysis to differentiate pancreatic neuroendocrine tumor grade 3 from neuroendocrine carcinoma
  • A. Azoulay, J. Cros, M.-P. Vullierme, L. de Mestier, A. Couvelard, O. Hentic, P. Ruszniewski, A. Sauvanet, V. Vilgrain, M. Ronot

Benvenuto su EM|consulte, il riferimento dei professionisti della salute.

Il mio account


Dichiarazione CNIL

EM-CONSULTE.COM è registrato presso la CNIL, dichiarazione n. 1286925.

Ai sensi della legge n. 78-17 del 6 gennaio 1978 sull'informatica, sui file e sulle libertà, Lei puo' esercitare i diritti di opposizione (art.26 della legge), di accesso (art.34 a 38 Legge), e di rettifica (art.36 della legge) per i dati che La riguardano. Lei puo' cosi chiedere che siano rettificati, compeltati, chiariti, aggiornati o cancellati i suoi dati personali inesati, incompleti, equivoci, obsoleti o la cui raccolta o di uso o di conservazione sono vietati.
Le informazioni relative ai visitatori del nostro sito, compresa la loro identità, sono confidenziali.
Il responsabile del sito si impegna sull'onore a rispettare le condizioni legali di confidenzialità applicabili in Francia e a non divulgare tali informazioni a terzi.


Tutto il contenuto di questo sito: Copyright © 2024 Elsevier, i suoi licenziatari e contributori. Tutti i diritti sono riservati. Inclusi diritti per estrazione di testo e di dati, addestramento dell’intelligenza artificiale, e tecnologie simili. Per tutto il contenuto ‘open access’ sono applicati i termini della licenza Creative Commons.